Gene-Edited Dogs Could End Pet Allergies
Scientists create first allergen-free dogs using CRISPR gene editing technology
1Overcoming the Allergy Barrier
Scientist Matt Walker, who suffered from dog allergies, dreamed of pet ownership. While working with CRISPR gene-editing technology at Harvard and Columbia University, he realized its potential to create hypoallergenic dogs. In 2020, he founded Kindred Companion Sciences to pursue this vision. After two years of research, Bailey and Alfie—two beagles—emerged as the world's first gene-edited dogs lacking the protein that causes allergic reactions in humans.
2Eliminating Allergens with CRISPR
The team targeted the Can f 1 protein, responsible for most dog allergies, using CRISPR to disable the gene that produces it. They edited skin cells from a female beagle, then used somatic cell nuclear transfer to clone embryos. After creating 25 edited embryos, they implanted them in a surrogate. Two developed successfully, resulting in healthy puppies that completely lacked the problematic protein in their saliva and dander.
3Rigorous Scientific Validation
DNA sequencing confirmed the successful gene edit, while biochemical tests showed undetectable levels of Can f 1 protein—unlike in control samples from regular beagles, poodles and golden doodles. Walker even subjected himself to skin prick tests, proving he could handle the edited dogs without allergic reactions. Veterinary examinations confirmed the puppies had normal birth weights and no congenital abnormalities.
4Real-World Living Proof
Walker has lived allergy-free with Bailey for eighteen months, playing with and handling the dog without any sneezing, itching or watery eyes—typical allergic responses he would get from regular dogs. Alfie lives with co-founder Nick Gavin under similar conditions. Both dogs undergo regular health checkups, with no signs of off-target genetic mutations or other health concerns related to the editing process.
5Precedent in Feline Research
Previous attempts at hypoallergenic pets included Virginia-based InBio's 2021 work editing cat allergens, though they didn't produce live cats. In 2024, South Korean researchers created Alsik, a gene-edited cat with 'extremely low' levels of the Fel d 1 allergen compared to normal felines. These projects demonstrated the feasibility of CRISPR applications for pet allergies before Kindred's canine breakthrough.
6Expanding to Service Dogs
While starting with beagles—common in research—Kindred plans to extend their technology to other breeds, particularly service dogs. Their strategy involves creating 'founder animals' that can naturally breed more allergen-free offspring. Walker explains that when two edited dogs mate, their puppies will inherit the edited gene. However, the company hasn't announced a timeline for commercial availability, as they prioritize responsible development over rapid commercialization.
7Ethical Boundaries in Gene Editing
Walker emphasizes using CRISPR only for legitimate health purposes, contrasting with companies like Texas-based Embryo Corporation that pursue glow-in-the-dark rabbits and unicorns. UC Berkeley's Fyodor Urnov praises Kindred's approach: 'Editing should solve real human problems.' The technology could also address breed-specific health issues without altering desirable traits, representing a responsible application of genetic engineering.
8A Revolution in Pet Ownership
This breakthrough offers hope for millions with dog allergies—over 50% of whom react to Can f 1 protein, according to allergy associations. Even 'hypoallergenic' breeds often carry significant allergen levels. Kindred's work demonstrates how science can remove barriers to pet companionship. For Walker, the personal reward matches the scientific achievement: 'Bailey has brought incredible joy and activity into my life,' he says, finally able to experience the bond between humans and their best friends.
Original article: Science Latest — Gen Düzenlemeli Köpekler Alerjiyi Tarihe Karıştırıyor